Genital Infiltrations of CD4+ and CD8+ T Lymphocytes, IgA+ and IgG+ Plasma Cells and Intra-Mucosal Lymphoid Follicles Associate With Protection Against Genital Chlamydiatrachomatis Infection in Minipigs Intramuscularly Immunized With UV-Inactivated Bacteria Adjuvanted With CAF01

Frontiers in Microbiology
Karin ErneholmFrank Follmann

Abstract

The development of a vaccine against genital chlamydia in women is advancing, and the evaluation of in situ immune responses following vaccination and challenge infections is crucial for development of a safe and protective vaccine. This study employs the sexually mature minipig model to characterize the genital in situ immune response to Chlamydia trachomatis infection in pigs previously immunized intramuscularly with UV-inactivated C. trachomatis serovar D (UV-SvD) adjuvanted/formulated with CAF01 adjuvant compared to a CAF01-alone control group. Pigs immunized with UV-SvD were significantly protected against vaginal challenge with C. trachomatis on day 3 post inoculation and showed significantly higher cervical infiltrations of approximately equal numbers of CD4+ and CD8+ T-cells, and IgG+ and IgA+ plasma cells compared to adjuvant-alone immunized controls. These immunological signatures correspond to findings in mice and are similar to those described in female chlamydia patients. This proves important potential for the pig model in elucidating immunological in situ signatures in future translational research in chlamydia vaccinology.

References

Jan 1, 1994·Methods in Enzymology·R G Rank, J A Whittum-Hudson
Dec 3, 1999·Human Reproduction Update·J Paavonen, W Eggert-Kruse
Nov 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hang LuRobert C Brunham
Feb 3, 2005·Nature Reviews. Immunology·Robert C Brunham, José Rey-Ladino
Oct 17, 2006·The Journal of Infectious Diseases·Anja Weinreich OlsenMichael Theisen
Jul 8, 2008·Developmental and Comparative Immunology·Wilhelm GernerArmin Saalmüller
Sep 19, 2008·American Journal of Reproductive Immunology : AJRI·Mercedes FicarraAlison J Quayle
Dec 3, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T AgrawalA Mittal
May 28, 2010·The Journal of Infectious Diseases·Catherine L HaggertyRoberta B Ness
Sep 18, 2010·Journal of Medical Microbiology·Katelijn SchautteetDaisy Vanrompay
Jan 15, 2011·Journal of Leukocyte Biology·Lynsey FairbairnDavid A Hume
Aug 27, 2011·Infectious Diseases in Obstetrics and Gynecology·Jason D BellDorothy L Patton
Nov 3, 2011·Expert Review of Vaccines·Joseph U IgietsemeCarolyn M Black
Dec 14, 2011·Trends in Microbiology·François MeurensVolker Gerdts
Jul 10, 2013·Infection and Immunity·Evelien De ClercqDaisy Vanrompay
Jan 31, 2014·Science Translational Medicine·Leonel MaldonadoCornelia L Trimble
Jan 21, 2016·Infection and Immunity·Raymond M Johnson, Robert C Brunham
Nov 28, 2017·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Tobias KäserFrançois Meurens

❮ Previous
Next ❯

Methods Mentioned

BETA
flow
enzyme-linked immunosorbent assays
Protein Assay
ELISA

Software Mentioned

Graph Pad Prism

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.